The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Postoperative Pain Management Market - 2026-2033
US$ 3,400.00
Postoperative Pain Management Market reached US$ 41.17 Billion in 2024 and is expected to reach US$ 65.36 Billion by 2033, growing with a CAGR of 5.40% during the forecast period 2026-2033. The Postop...
June 2026
55 pages
Global KSK7653 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global KSK7653 market size is expected to reach $ 321 million by 2032, rising at a market growth of 24.1% CAGR during the forecast period (2026-2032). In 2025, global HSK7653 production reached ap...
June 2026
88 pages
Americas Total IV Solutions Market Size and Forecast (2021 - 2034), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Non-Premixed IV and Premixed IV Products), End User [Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Home Care Settings, and Others], and Geography (North America and South and Central America)
US$ 3,450.00
The Americas Total IV Solutions Market is anticipated to grow from US$ 4.91 billion in 2025 to US$ 10.41 billion by 2034, with a CAGR of 8.7% during 2026–2034. The total IV solutions market growth is...
June 2026
235 pages
Bleeding Disorders Treatment Market Report by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others), Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), End User (Hospitals, Clinics, Academic and Research Institutes), and Region 2026-2034
US$ 2,999.00
The global bleeding disorders treatment market size reached USD 16.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.3 Billion by 2034, exhibiting a growth rate (CAGR)...
June 2026
144 pages
Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2026-2034
US$ 2,999.00
The global intravenous (IV) ibuprofen market size reached USD 7.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.6 Billion by 2034, exhibiting a growth rate (CAGR) of...
June 2026
149 pages
Pharmaceutical Fine Chemicals Market Report by Type (Proprietary, Non-proprietary), Product (Active Ingredients, Basic Building Blocks, Advanced Intermediates), Size (Big Molecules, Small Molecules), Application (Cardiovascular, Neurological, Oncological, Respiratory, Gastrointestinal, Musculoskeletal, and Others), and Region 2026-2034
US$ 2,999.00
The global pharmaceutical fine chemicals market size reached USD 157.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 250.6 Billion by 2034, exhibiting a growth rate (CA...
June 2026
143 pages
